Skip to content

understanding the effect periodontal treatment on type 2 diabetes mellitus subjects

Effect of Non Surgical Periodontal therapy in patients with Periodontitis and Type 2 Diabetes Mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/033985
Enrollment
180
Registered
2021-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: clinical periodontal parameters, salivary biomarker: Plaque index, Modified gingival index, Probing depth,Bleeding on probing, Recession, Loss of attachment will be measured using UNC 1

Sponsors

Haldia Institute of dental sciences and research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with Gingivitis : full mouth bleeding on probing less than 10% of sites. Subjects with Periodontitis : Subjects with Periodontitis with interdental clinical attachment loss detectable at >- 2 non adjacent teeth .Buccal or oral clinical attachment loss >-3 mm with pocketing > 3mm is detectable at >-2 teeth. Subjects with Periodontally Healthy (PH) : Subjects with PH will have no history of periodontitis, no sites with PD and CAL > 3 mm concurrently and no more than 10% of the sites with gingival bleeding and/or BoP. Diabetic subjects :The diabetic subjects will require a diagnosis of DM confirmed by a physician, dating from at least 2 years prior to the study. In addition, all diabetic patients will be required to have a HbA1c > 6.5% and FPG > 99 mg/dl. Non-diabetics: Non-diabetic subjects will have no history of DM, HbA1c = 6.0% and FPG

Exclusion criteria

Exclusion criteria: Pregnancy; breastfeeding; subgingival periodontal therapy during the previous 12 months; use of antibiotic, anti-inflammatory, and/or immunosuppressive therapies during the previous 6 months; regular use of mouthrinses containing antimicrobials; use of orthodontic appliances; presence of other infectious, immunological, and/or inflammatory systemic conditions (e.g., immunological disorders, rheumatoid arthritis) and major complications of DM (i.e.,ulcers, gangrene, amputation, neuropathy, and nephropathy),smokers.

Design outcomes

Primary

MeasureTime frame
changes in clinical periodontal status, salivary biomakers level and markers of diabetes controlTimepoint: at 3, 6 and 12 months after non surgical periodontal therapy.

Secondary

MeasureTime frame
Oral health behaviour and Quality of life assessmentTimepoint: 3,6 and 12 months

Countries

India

Contacts

Public ContactSwet Nisha

Haldia Institute of Dental Sciences and Research,Division Of Dentistry,Department Of Periodontology

drsavanshetty@gmail.com7595800724

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026